Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.120
-0.010 (-0.88%)
May 13, 2025, 4:00 PM - Market closed
Mustang Bio Employees
Mustang Bio had 6 employees as of December 31, 2024. The number of employees decreased by 74 or -92.50% compared to the previous year.
Employees
6
Change (1Y)
-74
Growth (1Y)
-92.50%
Revenue / Employee
n/a
Profits / Employee
-$2,625,333
Market Cap
3.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBIO News
- 2 months ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 3 months ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 3 months ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 3 months ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 4 months ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire
- 6 months ago - Mustang Bio Receives Positive Listing Determination from Nasdaq - GlobeNewsWire
- 6 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - GlobeNewsWire